PROMIMIC AB
Research PROMIMIC AB (B0T) on Bullrun: market cap EUR 15.02M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerB0T
- ExchangeF
- CountrySweden
- SectorHealthcare
- IndustryMedical Devices
- CurrencyEUR
- Market capEUR 15.02M
- Financial periodQ1 2026
- RevenueSEK 8.84M
- Net income-SEK 3.49M
- Free cash flowSEK 1.62M
- Gross margin89.8%
Valuation Snapshot
latest market cap is EUR 15.02M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | SEK 44.42M | -SEK 8.75M | -SEK 4.20M | 99.5% | -0.46 | SEK 20.63M | SEK 0 | SEK 59.11M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-24 | EUR 15.02M | n/a | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 EUR.
About PROMIMIC AB
Promimic AB (publ) engages in the manufacturing, marketing, and sale of biomaterials for improved osseointegration in the orthopedic and dental implants markets in Sweden. It offers HAnano surface which combines several properties that are known to improve osseointegration into one unique surface modification; and nano-sized crystalline powder or suspension hydroxyapatite can be used in r and d, as an ingredient in bone substitutes or as a chromatography material.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is PROMIMIC AB's market cap?
PROMIMIC AB's market capitalization is EUR 15.02M.
What does PROMIMIC AB do?
Promimic AB (publ) engages in the manufacturing, marketing, and sale of biomaterials for improved osseointegration in the orthopedic and dental implants markets in Sweden. It offers HAnano surface which combines several properties that are known to improve osseointegration into one unique surface modification; and nano-sized crystalline powder or suspension hydroxyapatite can be used in r and d, as an ingredient in bone substitutes or as a chromatography material. The company was incorporated in 2004 and is headquartered in Mölndal, Sweden.